Madam Métivier, you mentioned that the situation for small R and D companies is difficult, specifically with respect to venture capital. At a previous committee, I heard you mention that you would be ready to share the views you offered, and I'd like to ask you to provide them to us.
How would you differentiate BDC from private companies that provide venture capital to firms? Are you basically the same, or are you different?